Focus

Computational Biology Investors: Angels and VC Firms

The RaiseHunt database lists 41 Computational Biology investors: 37 angel investors and 4 people at 3 firms. Most list Seed and Series A among their stages; the largest hubs are San Francisco, London and Singapore.

Strongest in San Francisco, London and Singapore

Common stages: Seed and Series A

41
Computational Biology investors
37
Angel investors
4
People at VC/PE firms
3
Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

41 Computational Biology investors

Showing 1-20

Filters
Emily Melton
Emily Melton

Founder and Managing Partner

Portola Valley, United States
AngelOperator angel
AIHealthcare
View profile
Matthew De Silva
Matthew De Silva

Venture Partner

Chicago, United States
AngelOperator angel
AIHealthcare
View profile
Elad Gil
Elad Gil

Co-founder

San Francisco, United States
AngelOperator angel
AIFinTech
View profile
Alap Bharadwaj
Alap Bharadwaj

Global Lead and Director, Gemini-for-Good

Singapore
Angel
AIHardware
View profile
Dheeraj Pandey
Dheeraj Pandey

Co-founder

Los Gatos, United States
AngelOperator angel
AIHealthcare
View profile
Demis Hassabis
Demis Hassabis

Co-Founder & CEO

London, United Kingdom
AngelOperator angel
AIHealthcare
View profile
John Leonard
John Leonard

Board Member

Cambridge, United States
Angel
AIHealthcare
View profile
Simon Crosby
Simon Crosby

CTO

Kirkland, United States
AngelOperator angel
AIHardware
View profile
Zachary Bogue
Zachary Bogue

Cofounder and Managing Partner

San Francisco, United States
Angel
AIClimate
View profile
Blake Borgeson
Blake Borgeson

angel investor and operator angel

Austin, United States
AngelOperator angel
AIHealthcare
View profile
Alice Zhang
Alice Zhang

angel investor and operator angel

San Francisco, United States
AngelOperator angel
AIHealthcare
View profile
Mark Stoner
Mark Stoner

angel investor and operator angel

San Francisco, United States
AngelOperator angel
AIFinTech
View profile
Loong Wang
Loong Wang

angel investor

Singapore
Angel
AIHardware
View profile
Chris Wiggins
Chris Wiggins

Associate Professor

New York, United States
AngelOperator angel
AIEducation
View profile
Chris Leiter
Chris Leiter

Founder & General Partner

San Francisco, United States
AngelOperator angel
AIHealthcare
View profile
Rob Kniaz
Rob Kniaz

Partner Emeritus

London, United Kingdom
Angel
AIHealthcare
View profile
Ori Choshen
Ori Choshen

angel investor and operator angel

Tel Aviv-Yafo, Israel
AngelOperator angel
AIHealthcare
View profile
Ian Goodfellow
Ian Goodfellow

angel investor and operator angel

San Francisco, United States
AngelOperator angel
AIHealthcare
View profile
DW
David Walt

Hansjörg Wyss Professor of Biologically Inspired Engineering

Boston, United States
AngelOperator angel
AIHealthcare
View profile
AZ
Aaron Zucker

Founder & Managing Partner

Israel
AngelOperator angel
AIHardware
View profile

Frequently asked questions

How many Computational Biology investors are on RaiseHunt?

RaiseHunt currently lists 41 Computational Biology investors.

Are Computational Biology investors angels or funds?

Both. 37 are angel investors putting in their own money, and 4 are people making investment decisions at 3 firms.

Where are most Computational Biology investors based?

The largest concentrations are in San Francisco, London and Singapore.

What stage do Computational Biology investors invest at?

Most list Seed and Series A among the rounds they take part in.

How do I contact Computational Biology investors?

Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.

Is the list of Computational Biology investors free to browse?

Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.

Do Computational Biology investors only back Computational Biology companies?

No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.

What should I have ready before reaching out?

A short deck, a one-paragraph description of what you do and who it is for, and a clear number for how much you are raising. Investors read the first two lines before they decide whether to open the deck, so those lines matter more than the rest of the document.

Does a warm introduction still matter?

It helps, mostly because it moves your email out of a crowded inbox. It is not a requirement. A cold message that shows you understand what someone has already backed, and why your company fits that pattern, gets read more often than a vague introduction from a distant contact.

How do I know which Computational Biology investors are a fit?

Look at what they have already funded rather than what their profile says they like. Stage matters most, then sector, then geography. An investor who has never funded anything at your stage is unlikely to start with you, however well the sector lines up.

How long does raising a round usually take?

Longer than most first-time founders plan for. The work splits into building the list, running outreach, taking meetings, and closing, and each stage can stretch. Start before you need the money, not when the runway is short.

What do investors look at first?

The team and the problem, in that order, before the product. Early on there is rarely enough traction to argue from numbers alone, so the question they are answering is whether these particular people are likely to work this problem out.

Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal